October 2nd, 2010
Shilo Inn Airport
11707 NE Airport Way,
Portland, OR 97220
3:15pm- 4:45pm-- Session II
5:00pm- 6:30pm-- Session III
Jennifer Knipling, BCBA
detailed descriptions of each session's presentations: pdf or MSWord
Welcome to the blog for the Oregon Association for Behavior Analysis. Companion blog to the OR-ABA website: http://www.oraba.pbworks.com
pp. 4-5, "Consumer Corner: Maine Releases Report on Evidence-Based Practice for Autism"[End of Update 1]**
Lora Perry, M.S., BCBA
SCIENCE IN AUTISM TREATMENT: Newsletter of the Association for Science in Autism Treatment. Vol. 7 No. 1, Winter 2010.
"The meeting and consensus report were sponsored by the Autism Forum. The forum's goal in this initiative is to establish best practices for the care of co-occurring medical conditions that may affect the developmental outcome of persons with ASDs. Autism Forum programs are developed under the guidance of the Northwest Autism Foundation and in association with, and support of, the Autism Research Institute, Autism Society of America, and Easter Seals Oregon."
"The guidance in this article is not intended to advocate for an exclusive course of treatment or to represent a standard of medical care. Individual circumstances will determine variations that may be appropriate."
Autism spectrum disorders (ASDs) are common and clinically heterogeneous neurodevelopmental disorders. Gastrointestinal disorders and associated symptoms are commonly reported in individuals with ASDs, but key issues such as the prevalence and best treatment of these conditions are incompletely understood. A central difficulty in recognizing and characterizing gastrointestinal dysfunction with ASDs is the communication difficulties experienced by many affected individuals. A multidisciplinary panel reviewed the medical literature with the aim of generating evidence-based recommendations for diagnostic evaluation and management of gastrointestinal problems in this patient population. The panel concluded that evidence-based recommendations are not yet available. The consensus expert opinion of the panel was that individuals with ASDs deserve the same thoroughness and standard of care in the diagnostic workup and treatment of gastrointestinal concerns as should occur for patients without ASDs. Care providers should be aware that problem behavior in patients with ASDs may be the primary or sole symptom of the underlying medical condition, including some gastrointestinal disorders. For these patients, integration of behavioral and medical care may be most beneficial. Priorities for future research are identified to advance our understanding and management of gastrointestinal disorders in persons with ASDs.Pediatrics 2010;125:S1–S18
Children with autism spectrum disorders (ASDs) can benefit from adaptation of general pediatric guidelines for the diagnostic evaluation of abdominal pain, chronic constipation, and gastroesophageal reflux disease. These guidelines help health care providers determine when gastrointestinal symptoms are self-limited and when evaluation beyond a thorough medical history and physical examination should be considered. Children with ASDs who have gastrointestinal disorders may present with behavioral manifestations. Diagnostic and treatment recommendations for the general pediatric population are useful to consider until the development of evidence-based guidelines specifically for patients with ASDs. Pediatrics 2010;125:S19–S29
"Objective To conduct a randomized, controlled trial to evaluate the efficacy of the Early Start Denver Model (ESDM), a comprehensive developmental behavioral intervention, for improving outcomes of toddlers diagnosed with autism spectrum disorder (ASD).Two of the authors of the study are from University of Washington Autism Center, Center on Human Development and Disability, and the Department of Speech and Hearing Science, Portland State University, Portland, Oregon.
Methods: Forty-eight children diagnosed with ASD between 18 and 30 months of age were randomly assigned to 1 of 2 groups: (1) ESDM intervention, which is based on developmental and applied behavioral analytic principles and delivered by trained therapists and parents for 2 years; or (2) referral to community providers for intervention commonly available in the community.
Results: Compared with children who received community-intervention, children who received ESDM showed significant improvements in IQ, adaptive behavior, and autism diagnosis. Two years after entering intervention, the ESDM group on average improved 17.6 standard score points (1 SD: 15 points) compared with 7.0 points in the comparison group relative to baseline scores. The ESDM group maintained its rate of growth in adaptive behavior compared with a normative sample of typically developing children. In contrast, over the 2-year span, the comparison group showed greater delays in adaptive behavior. Children who received ESDM also were more likely to experience a change in diagnosis from autism to pervasive developmental disorder, not otherwise specified, than the comparison group.
Conclusions: This is the first randomized, controlled trial to demonstrate the efficacy of a comprehensive developmental behavioral intervention for toddlers with ASD for improving cognitive and adaptive behavior and reducing severity of ASD diagnosis. Results of this study underscore the importance of early detection of and intervention in autism."
CNN: "...[Sally] Rogers acknowledges that this study is only the first step. "Every piece of science needs to be replicated before it becomes fact, so we are currently doing a replication study," she said...."
Time: "...Whether the Early Start Denver Model will prove to be more effective than other therapies remains to be seen. Leading autism researcher Tristram Smith, an ABA expert at the University of Rochester, who lauds the new study for its methodological rigor, notes that the gains made by children in the intervention group were similar to those reported in studies of ABA models. "I do think there is a need for head-to-head studies," says Smith. Also needed is high-quality research on how to match individual children with the therapy that suits them best."
“Medication alone has been shown to help with some symptoms of autism, but its potential is limited...This study shows promise of a more effective treatment protocol that could improve life for children with autism and their families."
"Children with autism experienced fewer behaviors and needed less medication when their parents used behavior therapy in addition to medication, new research shows."

"...The findings of the National Standards Project include the identification of:----------------------------
11 “Established” Treatments: treatments that produce beneficial outcomes and are known to be effective for individuals on the autism spectrum. The overwhelming majority of these interventions were developed in the behavioral literature (e.g., applied behavior analysis, behavioral psychology, and positive behavior support).
22 “Emerging” Treatments: treatments that have some evidence of effectiveness, but not enough for us to be confident that they are truly effective.
5 “Unestablished” Treatments: treatments for which there is no sound evidence of effectiveness. There is no way to rule out the possibility these treatments are ineffective or harmful.
The National Standards Report encourages parents, educators, and service providers to use this information about treatment effectiveness as they make decisions about which treatments to select. It also strongly advises decision makers to consider other factors in addition to treatment effectiveness, including the judgment and data-based clinical recommendations of qualified professional(s), the values and preferences of the individual with ASD and those who care for him/her, and the capacity of their local schools and/or treatment programs to deliver the treatment correctly.
The project identified significant limitations of current autism treatment research. The National Autism Center is hopeful that the results of the project will encourage the research community to concentrate its efforts and conduct more research in areas that have not been studied adequately. In addition, research on all treatments should be extended to appropriate age groups, treatment targets, and diagnostic populations. "
Disclaimer
The Oregon Association for Behavior Analysis (OR-ABA) posts items only as a service to OR-ABA members and other interested persons. OR-ABA reserves the right to edit items submittedfor content, length, and style. OR-ABA will post only those event announcements that appear to be consistent with OR-ABA's statement of purpose, relevant laws, regulations, and ethical principles. OR-ABA's decision in this regard is final. These announcements should not construed as advertisements or endorsements of the products, services, or events described. OR-ABA cannot accept paid advertising on these pages. Announcements of commerical events or events with strong commercial tie-ins will be carefully evaluated for suitability. OR-ABA makes no representation of the accuracy of the events announcements, the quality of the events described, or suitability of any event or its intended use.
Please visit our website to find out more about OR-ABA, our activities, monthly meetings and speakers.